11 Podcast Episodes
Negotiating Prescription Drug Prices with Prof. Aaron Kesselheim
Negotiating Prescription Drug Prices with Prof. Aaron Kesselheim
The Inflation Reduction Act of 2022 is a lot of things…including a healthcare reform bill. Along with extending healthca... Read more
16 Aug 2022
•
41mins
Aducanumab (Aduhelm) for the Treatment of Alzheimers: A Podcast with Aaron Kesselheim and Jason Karlawish
Aducanumab (Aduhelm) for the Treatment of Alzheimers: A Podcast with Aaron Kesselheim and Jason Karlawish
On June 7th, 2021 FDA approved the amyloid beta-directed antibody aducanumab (Aduhelm) for the Treatment of Alzheimers. ... Read more
29 Jul 2021
•
44mins
Big Pharma’s big fraud with Dr. Aaron Kesselheim
Big Pharma’s big fraud with Dr. Aaron Kesselheim
Abdul dissects the FDA’s disastrous decision to approve the new Alzheimer’s drug aducanumab despite the evidence that it... Read more
27 Jul 2021
•
35mins
155. It’s The Prices Stupid! Guests, Aaron Kesselheim and Jonathan Darrow.
155. It’s The Prices Stupid! Guests, Aaron Kesselheim and Jonathan Darrow.
I am joined by Aaron Kesselheim and Jonathan Darrow, faculty members at Harvard Medical School and members of the Progra... Read more
15 Mar 2019
•
40mins
107. Prescription Drug Price Metrics. Guests, Aaron Kesselheim & Ameet Sarpatwari.
107. Prescription Drug Price Metrics. Guests, Aaron Kesselheim & Ameet Sarpatwari.
Two of the nation’s leading researchers into prescription drug costs join us for an in-depth exploration of the reasons ... Read more
4 Aug 2017
•
40mins
Aaron Kesselheim on the 21st Century Cures Act
Aaron Kesselheim on the 21st Century Cures Act
This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and W... Read more
1 Dec 2015
•
14mins
Aaron Kesselheim on the 21st Century Cures Act
Aaron Kesselheim on the 21st Century Cures Act
This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and W... Read more
1 Dec 2015
•
14mins
An interview with Drs. Aaron Kesselheim and Joel Gallant
An interview with Drs. Aaron Kesselheim and Joel Gallant
In the eighth installment of the OFID podcast, Editor Paul Sax, MD, delves into the headline-making pyrimethamine (Darap... Read more
12 Nov 2015
•
26: Guest Aaron Kesselheim
26: Guest Aaron Kesselheim
Guest Aaron Kesselheim. EHR gag clauses, ACOs, the state of drug safety & price regulation & Kim Kardashian
17 Sep 2015
•
39mins
NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.
NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.
Aaron Kesselheim is an associate professor of medicine at Harvard Medical School and a member of the Division of Pharmac... Read more
17 Jun 2015
•
12mins